Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01343043
Title A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1c259T in HLA-A2+ Patients With Synovial Sarcoma (NY-ESO-1)
Acronym NY-ESO-1
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Adaptimmune
Indications
Therapies
Age Groups: senior | adult | child
Covered Countries USA


No variant requirements are available.